Genome Compiler Acquired By Twist Bioscience

April 6, 2016 | Genome Compiler Corporation, an Israeli-based company providing software for genetic engineers, molecular and synthetic biologists, has been acquired by Twist Bioscience Corporation, a San Francisco-based company accelerating science and innovation through rapid, high-quality DNA synthesis. Financial details of the transaction were not disclosed. Twist Bioscience says it intends to leverage Genome Compiler’s technology and expertise to drive a digital products portfolio, including an eCommerce solution with gene design capabilities, expected to be available in the second half of 2016. Under the terms of the agreement, the Genome Compiler research and development center in Israel will become Twist Bioscience’s first international site. Twist Bioscience intends to expand the center in Tel Aviv to advance its digital product and gene design capabilities. Genome Compiler was founded in 2011 by Amirav-Drory with colleagues from Intel: Nir Ben Moshe, Yogev Debbi and Roy Nevo. The company has raised $6 million to date from LionBirdVC, Autodesk, and private angel investors. Twist Bioscience raised $61 million in January this year, making the total raised in two rounds $133 million.